Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

Press releases published on August 12, 2026

Aug. 12, 2026

Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026

Indeterminate GlobeNewswire

Aug. 12, 2026

Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1

Indeterminate GlobeNewswire

Aug. 12, 2026

Reflect Scientific Reports More Than $1.4 Million in Freezer-System Sales to Biopharmaceutical Customers

Indeterminate GlobeNewswire

Aug. 12, 2026

NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

Indeterminate GlobeNewswire

Aug. 12, 2026

Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors

Indeterminate GlobeNewswire

Aug. 12, 2026

ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments

Indeterminate GlobeNewswire

Aug. 12, 2026

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

Altimmune Announces Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality

Indeterminate GlobeNewswire

Aug. 12, 2026

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance

Indeterminate GlobeNewswire

Aug. 12, 2026

Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434

Indeterminate GlobeNewswire

Aug. 12, 2026

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process

Indeterminate GlobeNewswire

Aug. 12, 2026

Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire